118 related articles for article (PubMed ID: 2562926)
21. Sulfatide decreases the resistance to stress-induced apoptosis and increases P-selectin-mediated adhesion: a two-edged sword in breast cancer progression.
Suchanski J; Grzegrzolka J; Owczarek T; Pasikowski P; Piotrowska A; Kocbach B; Nowak A; Dziegiel P; Wojnar A; Ugorski M
Breast Cancer Res; 2018 Nov; 20(1):133. PubMed ID: 30400820
[TBL] [Abstract][Full Text] [Related]
22. Enzyme activity and protein content of superoxide dismutase isozymes in human renal cell carcinoma.
Homma-Takeda S; Sasaki A; Kikushima M; Kumagai Y; Uchida K; Kawai K; Akaza H; Shimojo N
Res Commun Mol Pathol Pharmacol; 2000; 108(1-2):49-55. PubMed ID: 11758974
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of lipids in mouse brain cell cultures during development.
Siegrist HP; Bologa-Sandru L; Burkart T; Wiesmann U; Hofmann K; Herschkowitz N
J Neurosci Res; 1981; 6(3):293-301. PubMed ID: 6271983
[TBL] [Abstract][Full Text] [Related]
24. Quantitative measurement of in vivo sulfatide metabolism during development of the mouse brain: evidence for a large rapidly degradable sulfatide pool.
Burkart T; Hofmann K; Siegrist HP; Herschkowitz NN; Wiesmann UN
Dev Biol; 1981 Apr; 83(1):42-8. PubMed ID: 6113177
[No Abstract] [Full Text] [Related]
25. Enzymatic sulfation of glycosphingolipids in rat parotid salivary glands.
Zdebska E; Liau YH; Slomiany A; Slomiany BL
J Dent Res; 1983 Oct; 62(10):1026-30. PubMed ID: 6578228
[TBL] [Abstract][Full Text] [Related]
26. Mass spectrometric analysis reveals changes in phospholipid, neutral sphingolipid and sulfatide molecular species in progressive epilepsy with mental retardation, EPMR, brain: a case study.
Hermansson M; Käkelä R; Berghäll M; Lehesjoki AE; Somerharju P; Lahtinen U
J Neurochem; 2005 Nov; 95(3):609-17. PubMed ID: 16086686
[TBL] [Abstract][Full Text] [Related]
27. Significance of thymidine kinase activity in renal cell carcinoma.
Mizutani Y; Wada H; Yoshida O; Fukushima M; Nakao M; Miki T
J Urol; 2003 Feb; 169(2):706-9. PubMed ID: 12544347
[TBL] [Abstract][Full Text] [Related]
28. Menstrual cycle-associated regulation of anabolic and catabolic enzymes causes luteal phase-characteristic expression of sulfatide in human endometrium.
Kamei K; Kubushiro K; Fujii T; Tsukazaki K; Nozawa S; Iwamori M
Am J Obstet Gynecol; 1997 Jan; 176(1 Pt 1):142-9. PubMed ID: 9024105
[TBL] [Abstract][Full Text] [Related]
29. Effect of glucocorticoids on galactosylceramide sulfotransferase activity in rat brain.
Meyer JS; Czupryna M
Brain Res; 1982 Dec; 252(1):192-6. PubMed ID: 6959686
[TBL] [Abstract][Full Text] [Related]
30. Beta-galactosylceramide increases and sulfatide decreases cytokine and chemokine production in whole blood cells.
Roeske-Nielsen A; Fredman P; Mansson JE; Bendtzen K; Buschard K
Immunol Lett; 2004 Feb; 91(2-3):205-11. PubMed ID: 15019291
[TBL] [Abstract][Full Text] [Related]
31. 3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase. An optimized assay in homogenates of developing brain.
Burkart T; Siegrist HP; Herschkowitz NN; Wiesmann UN
Biochim Biophys Acta; 1977 Aug; 483(2):303-11. PubMed ID: 19067
[TBL] [Abstract][Full Text] [Related]
32. Developmental regulation of galactoglycerolipid and galactosphingolipid sulphation during mammalian spermatogenesis. Evidence for a substrate-selective inhibitor of testicular sulphotransferase activity in the rat.
Lingwood CA
Biochem J; 1985 Oct; 231(2):393-400. PubMed ID: 3864440
[TBL] [Abstract][Full Text] [Related]
33. Cysteine conjugate beta-lyase activity in human renal carcinomas.
Nelson JA; Pan BF; Swanson DA; Elfarra AA
Cancer Biochem Biophys; 1995 Jan; 14(4):257-63. PubMed ID: 7767899
[TBL] [Abstract][Full Text] [Related]
34. Glutathione S-transferase isoenzyme profile in non-tumor and tumor human kidney tissue.
Simić T; Mimić-Oka J; Ille K; Dragicević D; Savić-Radojević A
World J Urol; 2003 May; 20(6):385-91. PubMed ID: 12811499
[TBL] [Abstract][Full Text] [Related]
35. Glutathione S-transferase isoenzymes and glutathione in renal cell carcinoma and kidney tissue.
Gajewska J; Szczypka M; Pych K; Borówka A; Laskowska-Klita T
Neoplasma; 1995; 42(4):167-72. PubMed ID: 7659181
[TBL] [Abstract][Full Text] [Related]
36. The PGRMC1 Antagonist AG-205 Inhibits Synthesis of Galactosylceramide and Sulfatide.
Wang-Eckhardt L; Becker I; Eckhardt M
Cells; 2021 Dec; 10(12):. PubMed ID: 34944026
[TBL] [Abstract][Full Text] [Related]
37. The metabolic processing of glycosphingolipids in HT-29 cells is differentiation-dependent.
Houri JJ; Falbo A; Vignali G; Codogno P; Ghidoni R
Biochem Biophys Res Commun; 1994 Jul; 202(2):992-1000. PubMed ID: 8048973
[TBL] [Abstract][Full Text] [Related]
38. In-vitro biosynthesis of sulphatoglycosphingolipids by rat submandibular salivary glands.
Liau YH; Zdebska E; Aono M; Slomiany A; Slomiany BL
Arch Oral Biol; 1983; 28(11):1001-6. PubMed ID: 6581758
[TBL] [Abstract][Full Text] [Related]
39. Enhanced expression of sulfatide, a sulfated glycolipid, in well-differentiated endometrial adenocarcinoma.
Sugiyama T; Miyazawa M; Mikami M; Goto Y; Nishijima Y; Ikeda M; Hirasawa T; Muramatsu T; Takekoshi S; Iwamori M
Int J Gynecol Cancer; 2012 Sep; 22(7):1192-7. PubMed ID: 22801032
[TBL] [Abstract][Full Text] [Related]
40. Uroporphyrinogen decarboxylase and porphyrins in the tissue of human clear-cell renal carcinoma and in its maternal renal cortex.
Zawirska B
Neoplasma; 1989; 36(2):207-13. PubMed ID: 2716925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
